Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients

Japanese Journal of Infectious Diseases

Volumn 59, Issue 1, 2006, Pages 10-14

  Tamer, Ali ^a   Karabay, Oguz ^a   Ekerbicer, Hasan ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b KSU Medical School   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; COTRIMOXAZOLE; INSULIN; MACROLIDE; ORAL ANTIDIABETIC AGENT; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CARRIER; CONTROLLED STUDY; DEVICE INFECTION; DIETETICS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INSULIN TREATMENT; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CARRIER STATE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; NASAL CAVITY; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 33644529132     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Peacock, S.-J., Justice, A., Griffiths, D., de Silva, G.-D., Kantzanou, M.-N., Crook, D., Sleeman, K. and Day, N.-P. (2003): Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J. Clin. Microbiol., 41, 5718-5725.
2. Pujol, M., Pena, C., Pallares, R., Ayats, J., Ariza, J. and Gudiol, F. (1994): Risk factors for nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis., 13, 96-102.
3. Kluytmans, J., Belkum, A. and Verbrugh, H. (1997): Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanism, and associated risks. Clin. Microbiol. Rev., 10, 505-520.
4. Vandenbergh, M.-F. and Verbrugh, H.-A. (1999): Carriage of Staphylococcus aureus: Epidemiology and clinical relevance. J. Lab. Clin. Med., 133, 525-534.
5. Wenzel, R.-P. and Perl, T.-M. (1995): The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect., 31, 13-24.
6. Saliba, W.-R., Goldstein, L.-H., Raz, R., Mader, R., Colodner, R. and Elias, M.-S. (2003): Subacute necrotizing fasciitis caused by gas-producing Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis., 22, 612-614.
7. Akbar, D.-H. (2C01): Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol., 38, 77-82.
8. Tentolouris, N., Jude, E.-B., Smirnof, I., Knowles, E.-A. and Boulton, A.-J. (1999): Methicillin-resistant StaAhylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet. Med., 16, 767-771.
9. Herwaldt, L.-A. (2003): Staphylococcus aureus nasal carriage and surgical-site infections. Surgery, 134 (Suppl. 5), 2-9.
10. Boyko, E.-J., Lipsky, B.-A., Sandoval, R., Keane, E.-M., Monahan, J.-S., Pecoraro, R.-E. and Hamman, R.-F. (1989): NIDDM and prevalence of nasal Staphylococcus aureus colonization. San Luis Valley Diabetes Study. Diabetes Care, 12, 189-192.
11. Berman, D.-S., Schaefler, S., Simberkoff, M.-S. and Rahal, J.-J. (1987): Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetics. J. Infect. Dis., 155, 829-831.
12. Ahluwalia, A., Sood, A., Sood, A., Lakshmy, R., Kapil, A. and Pandey, R.-M. (2000): Factors affecting staphylococcal colonization among NIDDM outpatients. Diabet. Med., 17, 487-488.
13. Singh, G. and Rao, D.-J. (1975): Bacterial flora and the diabetic skin. Indian J. Med. Res., 63, 529-532.
14. Tuazon, C.-U., Perez, A., Kishaba, T. and Sheagren, J.-N. (1975): Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA, 231, 1272.
15. Lipsky, B.-A., Pecoraro, R.-E., Chen, M.-S. and Koespell, T.-D. (1987): Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care, 10, 483-486.
16. Chandler, P.-T. and Chandler, S.-D. (1977): Pathogenic carrier rate in diabetes mellitus. Am. J. Med. Sci., 273, 259-265.
17. Smith, J.-A. and O'Connor, J.-J. (1966): Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet, 2, 776-777.
18. Kuzuya, T., Nakagawa, S., Satoh, J., Kanazawa, Y., Iwamoto, Y., Kobayashi, M., Nanjo, K., Sasaki, A., Seino, Y., Ito, C., Shima, K., Nonaka, K. and Kadowaki, T. (2002): Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res. Clin. Pract., 55, 65-85.
19. Falanga, V., Campbell, D.-E., Leyden, J.- J. and Douglas, S.-D. (1985): Nasal carriage of Staphylococcus aureus and antistaphylococcal immunoglobulin E antibodies in atopic dermatitis. J. Clin. Microbiol., 22, 452-454.
20. Bartzokas, C.-A., Paton, J.-H., Gibson, M.-F., Graham, F., McLoughlin, G.-A. and Croton, R.-S. (1984): Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. New Engl. J. Med., 311, 1422-1425.
21. Breen, J.-D. and Karchmer, A.-W. (1995): Staphylococcus aureus infections in diabetic patients. Infect. Dis. Clin. North. Am., 9, 11-24.
22. Armstrong.-Esther, C.-A. (1976): Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann. Hum. Biol., 3, 221-227.
23. Nouwen, J.-L., Belkum, V.-A. and Verbrugh, H.-A. (2001): Determinants of Staphylococcus aureus nasal carriage. Neth. J. Med., 59, 126-133.
24. VandenBergh, M.-F., Yzerman, E.-P., van Belkum, A., Boelens, H.-A., Sijmons, M. and Verbrugh, H.-A. (1999): Follow-up of Staphylococcus aureus nasal carriage after 8 years: Redefining the persistent carrier state. J. Clin. Microbiol., 37, 3133-3140.
25. Warshawsky, B., Hussain, Z., Gregson, D.-B., Alder, R., Austin, M., Bruckschwaiger, D., Chagla, A.-H., Daley, J., Duhaime, C., McGhie, K., Pollett, G., Potters, H. and Schiedel, L. (2000): Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor. Infect. Control Hosp. Epidemiol., 21, 724-727.
26. Troillet, N., Carmeli, Y., Samore, M.-H., Dakos, J., Eichelberger, K., DeGirolami, P.-C. and Karchmer, A.-W. (1998): Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect. Control Hosp. Epidemiol., 19, 181-185.
27. Bassetti, S. and Battegay, M. (2004): Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies. Infection, 32, 163-169.
28. Pena, C., Fernandez-Sabe, N., Dominguez, M.-A., Pujol, M., Martinez-Castelao, A., Ayats, J., Gudiol, F. and Ariza, J. (2004): Staphylococcus aureus nasal carriage in patients on haemodialysis: Role of cutaneous colonization. J. Hosp. Infect., 58, 20-27.
29. Pray, W. S. (2002): Minor Wound Care for Diabetic, Patients. U.S. Pharmacist. Jobson Publication.
30. Dziekan, G., Hahn, A., Thune, K., Schwarzer, G., Schafer, K., Daschner, F.-D. and Grundmann, H. (2000): Methicillin-resistant Staphyloccus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study. J. Hosp. Infect., 46, 263-270.
31. Graffunder, E.-M. and Venezia, R.-A. (2002): Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J. Antimicrob. Chemother., 49, 999-1005.
32. Noble, W.-C., Williams, R.-E., Jevons, M.-P. and Shooter, R.-A. (1964): Some aspects of nasal carriage of staphylococci. J. Clin. Pathol., 17, 79-83.
33. Hawkey, P.-M. (1997): Quinolones in sweat and quinolone resistance. Lancet, 349, 148-149.
34. Hardy, K.-J., Hawkey, P.-M., Gao, F. and Oppenheim, B.-A. (2004): Methicillin-resistant Staphylococcus aureus in the critically ill. Br. J. Anaesth., 92, 121-130.
35. Hoiby, N., Jarlov, J.-O., Kemp, M., Tvede, M., Bangsborg, J.-M., Kjerulf, A., Pers, C. and Hansen, H. (1997): Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet, 349, 167-169.